metricas
covid
Buscar en
Clínica e Investigación en Arteriosclerosis
Toda la web
Inicio Clínica e Investigación en Arteriosclerosis Trans fatty acids, cardiovascular health, and policy implications
Información de la revista
Vol. 22. Núm. S2.
16.º Simposio Científico Alimentación, Lípidos y Aterosclerosis
Páginas 14-15 (diciembre 2010)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 22. Núm. S2.
16.º Simposio Científico Alimentación, Lípidos y Aterosclerosis
Páginas 14-15 (diciembre 2010)
Acceso a texto completo
Trans fatty acids, cardiovascular health, and policy implications
Visitas
1000
Dariush Mozaffarian
Department of Epidemiology and Nutrition, Harvard School of Public Health, Boston, MA, USA
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Recommended references
[European and Parliament., 2007]
European Parliament. Written declaration. Pusuant to Rule 116 of The Rules of Procedure by Jim Higgins, Dan Jorgensen, John Bowis and Linda McAvan on Trans Fatty Acids. 2007 Jan 31, 2007.
[Kavanagh et al., 2005]
K. Kavanagh, K.L. Jones, J. Sawyer, K. Kelley, J.J. Carr, J.D. Wagner, et al.
Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction.
J Nutr, 135 (2005), pp. 562-566
[Micha and Mozaffarian, 2009]
R. Micha, D. Mozaffarian.
Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes.
Nat Rev Endocrinol, 5 (2009), pp. 335-344
[Mozaffarian and Clarke, 2009]
D. Mozaffarian, R. Clarke.
Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils.
Eur J Clin Nutr, 63 (2009), pp. S22-S33
[Mozaffarian et al., 2006]
D. Mozaffarian, M.B. Katan, A. Ascherio, M.J. Stampfer, W.C. Willett.
Trans fatty acids and cardiovascular disease.
N Engl J Med, 354 (2006), pp. 1601-1613
[Mozaffarian et al., 2004]
D. Mozaffarian, E.B. Rimm, I.B. King, R.L. Lawler, G.B. McDonald, W.C. Levy.
Ttrans fatty acids and systemic inflammation in heart failure.
Am J Clin Nutr, 80 (2004), pp. 1521-1525
[Mozaffarian and Willett, 2007]
D. Mozaffarian, W.C. Willett.
Trans fatty acids and cardiovascular risk: a unique cardiometabolic imprint?.
Curr Atheroscler Rep, 9 (2007), pp. 486-493
[Mozaffarian, 2005]
D. Mozaffarian.
Effects of dietary fats versus carbohydrates on coronary heart disease: a review of the evidence.
Curr Atheroscler Rep, 7 (2005), pp. 435-445
[Obesity, 2007]
Obesity (Silver Spring). Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. 2007;15:1675-84.
[Vanden Heuvel, 2004]
J.P. Vanden Heuvel.
Diet, fatty acids, and regulation of genes important for heart disease.
Curr Atheroscler Rep, 6 (2004), pp. 432-440
Copyright © 2010. Sociedad Española de Arteriosclerosis y Elsevier España S.L.
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos